Navigation Links
ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
Date:9/27/2007

ormation can be found on the Company's web site at http://www.adventrx.com.

Forward Looking Statement

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors that, if they do not materialize or prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that preclinical results are not indicative of the success of subsequent clinical trials and that products will not perform as preclinical data suggests or as otherwise anticipated; the FDA's views on the appropriateness of seeking marketing approval of ANX-514 under Section 505(b)(2); difficulties or delays in developing, testing, manufacturing and marketing and obtaining regulatory approval for ANX-514, including receiving necessary regulatory approvals for clinical trials of ANX-514, in a timely manner or at all, and the potential for automatic injunctions regarding FDA approval of ANX-514 and other challenges by patent holders during the Section 505(b)(2) process; uncertainty under Section 505(b)(2) resulting from legal action against the FDA and the potential that future interpretations of Section 505(b)(2) could delay or prevent the FDA from approving any Section 505(b)(2) NDA; the potential for regulatory authorities to require additional preclinical work or other clinical requirements to support regulatory filings; patent and non-patent exclusivity covering docetaxel; the risk that ADVENTRX will be unable to raise sufficient capital to fund the projects necessary to meet its anticipated or stated goals and milestones, including funding the continued development of ANX-514; and other risks and uncertainties more fully des
'/>"/>

SOURCE ADVENTRX Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014   Lycera Corp ... breakthrough oral medicines to treat autoimmune disease and ... today announced the appointment of Harinder Singh ... advisory board.  Dr. Singh will lead the board,s ... Lycera,s multiple ongoing research programs and pipeline of ...
(Date:8/26/2014)... 2014 Trovagene, Inc. (NASDAQ:  TROV) presented ... Moving Assays to the Clinic with an ... Cell Free Tumor DNA in Urine." In this ... Precision Cancer Monitoring (PCM) platform and results from ... detection of tumor DNA mutations from urine samples ...
(Date:8/26/2014)... InstantGMP, Inc., the only cloud-based manufacturing ... pricing structure with increased user accounts to help current ... CFR Part 11 requirements. , “We want to help ... can” said Rick Soltero, President of InstantGMP. “We ... customers to have separate accounts for multiple quality managers ...
(Date:8/26/2014)... Spartan Bioscience today announced the ... Business Development. Mr. Shah is responsible for expanding ... in the United States and international markets. ... and strategic initiatives for the company’s rapid sample-to-result ... Shah was the Global Marketing Product Manager for ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4Spartan Bioscience Names Charudutt Shah as Director of Business Development 2
... April 4, 2008 Scientists in fields,as diverse ... from the Olympus FluoroPoint(TM) single molecule fluorescence,detection system ... of laboratories around the world, the system, with ... of use, is now,available for the first time ...
... April 4, 2008 Pharmasset,Inc. (Nasdaq: VRUS ) ... held on April 9, 2008 at the St. Regis ... Officer, will,provide an overview of the company,s clinical and ... To access a simultaneous webcast of Mr. Price,s ...
... MISSISSAUGA, ON, April 3 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ... the,three months ended February 29, 2008. All dollar amounts ... At February 29, 2008, our cash and cash equivalents ... 2007., We incurred a net loss for the ...
Cached Biology Technology:Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research 2Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research 3Pharmasset to Present at the Canaccord Adams Hepatitis C Conference on Wednesday, April 9th 2Vasogen Announces First Quarter 2008 Results 2Vasogen Announces First Quarter 2008 Results 3Vasogen Announces First Quarter 2008 Results 4Vasogen Announces First Quarter 2008 Results 5Vasogen Announces First Quarter 2008 Results 6Vasogen Announces First Quarter 2008 Results 7Vasogen Announces First Quarter 2008 Results 8Vasogen Announces First Quarter 2008 Results 9Vasogen Announces First Quarter 2008 Results 10Vasogen Announces First Quarter 2008 Results 11
(Date:8/25/2014)... Ill. Aug. 25, 2014 Riddell, the ... the Translational Genomics Research Institute (TGen), a leader ... Pac-12,s Arizona State University and its Sun Devil ... research study designed to advance athlete concussion detection ... the joint research project will combine molecular information ...
(Date:8/25/2014)... 2014  Scribe Labs unveiled its first product, ... saw its campaign surpass the $50,000 funding goal ... metrics that help an athlete understand how factors ... running mechanics. Built with an advanced 9-axis integrated ... advanced set of running metrics available outside of ...
(Date:8/25/2014)... Baltimore is one of the oldest cities in ... well. With these older buildings often comes a whole host of ... to be mold. Mold is often found in the rafters of ... in the walls often times due to older plumbing that has ... look for mold in regards to the area? Also, what can ...
Breaking Biology News(10 mins):Riddell, TGen team with ASU football to further genetic research into concussion detection 2Riddell, TGen team with ASU football to further genetic research into concussion detection 3runScribe Fitness Wearable Exceeds 200% of Kickstarter Goal in First Week 2Mold Concerns in Baltimore 2
... -- Sunshine Menezes, executive director of the Metcalf Institute for ... Mitchell announced the 2011 winner of The Grantham Prize for ... Economist will receive US$75,000 for "The World,s Lungs: Forests, and ... the state of global forests and the rising threats they ...
... In work published in the June 2011 issue ... and their co-investigators - a multidisciplinary team within the ... - have transferred the concept of redox-sensitive Green Fluorescent ... (FRET) imaging platform. For the FRET-based sensors, a change ...
... world or at least the nice temperate parts. They,ve ... sugar shipments from Argentina, and no native ant species has ... group of Stanford University undergraduate students working on a class ... ant, has been using chemical warfare to combat the Argentine ...
Cached Biology News:$75,000 Grantham Prize winner announced 2$75,000 Grantham Prize winner announced 3Development of a FRET sensor for real-time imaging of intracellular redox dynamics 2Development of a FRET sensor for real-time imaging of intracellular redox dynamics 3Native ants use chemical weapons to turn back invading Argentine ants 2Native ants use chemical weapons to turn back invading Argentine ants 3Native ants use chemical weapons to turn back invading Argentine ants 4
... Serum • Beagle serum is collected from ... year of age Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium ... Alsevers N-05: ACD N-07: ...
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein...
MOUSE ANTI BOVINE TROPONIN I...
Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG...
Biology Products: